Exuma Biotech

Cayman Islands
George Town, George Town, Cayman Islands

Company profile

Exuma Biotech company profile

EXUMA Biotech is a clinical-stage biotechnology company discovering and developing Chimeric Antigen Receptor (CAR)-T cell products for solid tumors. They develop new tools for the patient’s immune system to fight various solid tumor malignancies, such as renal cell carcinoma, soft tissue sarcoma, gastric cancer, and others. It was founded in 2015 and headquartered in Grand Cayman, Midland.

Business identity

Contact email
[email protected]
Phone number
1-345-232-0566
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2015-01-01, Year

Headquarters

Country code
KY
Continent
North America

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
4
Total equity funding
$107M
Last funding
Series B / $41M / 2021-12-21
Last equity funding
Series B / $41M
Investors
7
Lead investors
3
Articles
15

Founders and investors

Lead investors

Americo Financial Life and AnnuityF1 BioVenturesShanghai Sinobioway Sunterra Biotechnology

Investors

Americo Financial Life and AnnuityBioAtlaMSD PartnersShanghai Sinobioway Sunterra BiotechnologySunTerra Capital